ZIMMER BIOMET HOLDINGS, INC. Operating Expenses
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Operating Expenses of $1.73 billion for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2016-08-08
- ZIMMER BIOMET HOLDINGS, INC. operating expenses for the quarter ending 2016-06-30 was $1.73B, a 33.29% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. operating expenses for the quarter ending 2016-03-31 was $1.66B, a 91.84% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. operating expenses for the quarter ending 2015-12-31 was $1.72B, a 72.60% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. operating expenses for the quarter ending 2015-09-30 was $1.65B, a 93.49% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. operating expenses for fiscal 2015 was $5.53B, a 52.10% increase from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. operating expenses for fiscal 2014 was $3.64B, a 2.28% increase from fiscal 2013.
- ZIMMER BIOMET HOLDINGS, INC. operating expenses for fiscal 2013 was $3.55B, a 54.62% increase from fiscal 2012.
- ZIMMER BIOMET HOLDINGS, INC. operating expenses for fiscal 2012 was $2.30B, a 0.29% decline from fiscal 2011.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-06-30 | $1.73B 10-Q · filed 2016-08-08 | $3.39B 10-Q · filed 2016-08-08 | $5.11B derived: sum of 3 quarters · filed 2016-08-08 | $6.76B derived: sum of 4 quarters · filed 2016-08-08 | ||||
| 2016-03-31 | $1.66B 10-Q · filed 2016-05-10 | $3.38B derived: sum of 2 quarters · filed 2016-05-10 | $5.02B derived: sum of 3 quarters · filed 2016-05-10 | $6.32B derived: sum of 4 quarters · filed 2016-08-08 | ||||
| 2015-12-31 | $1.72B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.37B derived: sum of 2 quarters · filed 2016-02-29 | $4.67B derived: sum of 3 quarters · filed 2016-08-08 | $5.53B 10-K · filed 2016-02-29 | ||||
| 2015-09-30 | $1.65B 10-Q · filed 2015-11-09 | $2.95B derived: sum of 2 quarters · filed 2016-08-08 | $3.81B 10-Q · filed 2015-11-09 | $4.81B derived: sum of 4 quarters · filed 2016-08-08 | ||||
| 2015-06-30 | $1.30B 10-Q · filed 2016-08-08 | $1.01B 10-Q · filed 2015-08-10 | $2.16B 10-Q · filed 2016-08-08 | $1.59B 10-Q · filed 2015-08-10 | $3.16B derived: sum of 3 quarters · filed 2016-08-08 | $4.01B derived: sum of 4 quarters · filed 2016-08-08 | ||
| 2015-03-31 | $864.50M 10-Q · filed 2016-05-10 | $580.80M 10-Q · filed 2015-05-07 | $1.86B derived: sum of 2 quarters · filed 2016-05-10 | $2.71B derived: sum of 3 quarters · filed 2016-05-10 | $3.30B derived: sum of 4 quarters · filed 2016-05-10 | |||
| 2014-12-31 | $996.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.85B derived: sum of 2 quarters · filed 2016-02-29 | $2.44B derived: sum of 3 quarters · filed 2016-02-29 | $3.64B 10-K · filed 2016-02-29 | $2.39B 10-K · filed 2015-02-23 | |||
| 2014-09-30 | $850.80M 10-Q · filed 2015-11-09 | $556.50M 10-Q · filed 2014-11-05 | $1.44B derived: sum of 2 quarters · filed 2015-11-09 | $2.64B 10-Q · filed 2015-11-09 | $1.70B 10-Q · filed 2014-11-05 | $3.84B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $590.40M 10-Q · filed 2015-08-10 | $1.15B 10-Q · filed 2015-08-10 | $2.99B derived: sum of 3 quarters · filed 2016-02-29 | $3.52B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $557.70M 10-Q · filed 2015-05-07 | $2.40B derived: sum of 2 quarters · filed 2016-02-29 | $2.93B derived: sum of 3 quarters · filed 2016-02-29 | $3.56B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $1.84B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.37B derived: sum of 2 quarters · filed 2016-02-29 | $3.01B derived: sum of 3 quarters · filed 2016-02-29 | $3.55B 10-K · filed 2016-02-29 | $2.30B 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $533.80M 10-Q · filed 2014-11-05 | $1.17B derived: sum of 2 quarters · filed 2014-11-05 | $1.72B 10-Q · filed 2014-11-05 | $2.40B derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2013-06-30 | $635.50M 10-Q · filed 2014-08-07 | $1.18B 10-Q · filed 2014-08-07 | $1.86B derived: sum of 3 quarters · filed 2015-02-23 | $2.38B derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2013-03-31 | $547.80M 10-Q · filed 2014-05-06 | $1.23B derived: sum of 2 quarters · filed 2015-02-23 | $1.75B derived: sum of 3 quarters · filed 2015-02-23 | $2.29B derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2012-12-31 | $681.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $1.20B derived: sum of 2 quarters · filed 2015-02-23 | $1.74B derived: sum of 3 quarters · filed 2015-02-23 | $2.30B 10-K · filed 2015-02-23 | ||||
| 2012-09-30 | $520.40M 10-Q · filed 2013-11-12 | $1.06B derived: sum of 2 quarters · filed 2013-11-12 | $1.62B 10-Q · filed 2013-11-12 | $2.28B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $541.20M 10-Q · filed 2013-08-07 | $1.10B 10-Q · filed 2013-08-07 | $1.76B derived: sum of 3 quarters · filed 2014-02-28 | $2.27B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $556.40M 10-Q · filed 2013-05-08 | $1.22B derived: sum of 2 quarters · filed 2014-02-28 | $1.73B derived: sum of 3 quarters · filed 2014-02-28 | $2.32B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $662.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.18B derived: sum of 2 quarters · filed 2014-02-28 | $1.77B derived: sum of 3 quarters · filed 2014-02-28 | $2.31B 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $513.00M 10-Q · filed 2012-11-06 | $1.10B derived: sum of 2 quarters · filed 2012-11-06 | $1.64B 10-Q · filed 2012-11-06 | $2.38B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $590.40M 10-Q · filed 2012-08-07 | $1.13B 10-Q · filed 2012-08-07 | $1.87B derived: sum of 3 quarters · filed 2013-02-27 | $2.34B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $539.40M 10-Q · filed 2012-05-03 | $1.28B derived: sum of 2 quarters · filed 2013-02-27 | $1.75B derived: sum of 3 quarters · filed 2013-02-27 | $2.33B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $737.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.21B derived: sum of 2 quarters · filed 2013-02-27 | $1.79B derived: sum of 3 quarters · filed 2013-02-27 | $2.29B 10-K · filed 2013-02-27 | $2.29B 10-K · filed 2011-02-25 | |||
| 2010-09-30 | $474.30M 10-Q · filed 2011-11-02 | $474.20M 10-Q · filed 2010-11-03 | $1.05B derived: sum of 2 quarters · filed 2011-11-02 | $1.55B 10-Q · filed 2011-11-02 | $1.55B 10-Q · filed 2010-11-03 | $2.15B derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-06-30 | $579.00M 10-Q · filed 2011-08-08 | $1.08B 10-Q · filed 2011-08-08 | $1.67B derived: sum of 3 quarters · filed 2012-02-27 | $2.20B derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $500.30M 10-Q · filed 2011-05-05 | $1.09B derived: sum of 2 quarters · filed 2012-02-27 | $1.62B derived: sum of 3 quarters · filed 2012-02-27 | $2.10B derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $594.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $1.12B derived: sum of 2 quarters · filed 2012-02-27 | $1.60B derived: sum of 3 quarters · filed 2012-02-27 | $2.09B 10-K · filed 2012-02-27 | $2.09B 10-K · filed 2010-02-25 | |||
| 2009-09-30 | $522.30M 10-Q · filed 2010-11-03 | $1.01B derived: sum of 2 quarters · filed 2010-11-03 | $1.49B 10-Q · filed 2010-11-03 | $1.49B 10-Q · filed 2009-11-04 | $2.04B derived: sum of 4 quarters · filed 2011-02-25 | |||
| 2009-06-30 | $486.60M 10-Q · filed 2010-08-05 | $969.20M 10-Q · filed 2010-08-05 | $969.10M 10-Q/A · filed 2009-08-17 | $1.52B derived: sum of 3 quarters · filed 2011-02-25 | $2.02B derived: sum of 4 quarters · filed 2011-02-25 | |||
| 2009-03-31 | $482.60M 10-Q · filed 2010-05-05 | $1.03B derived: sum of 2 quarters · filed 2011-02-25 | $1.53B derived: sum of 3 quarters · filed 2011-02-25 | $2.04B derived: sum of 4 quarters · filed 2011-02-25 | ||||
| 2008-12-31 | $547.40M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $1.05B derived: sum of 2 quarters · filed 2011-02-25 | $1.56B derived: sum of 3 quarters · filed 2011-02-25 | $2.03B 10-K · filed 2011-02-25 | ||||
| 2008-09-30 | $504.70M 10-Q · filed 2009-11-04 | $1.01B derived: sum of 2 quarters · filed 2009-11-04 | $1.49B 10-Q · filed 2009-11-04 | |||||
| 2008-06-30 | $508.80M 10-Q/A · filed 2009-08-17 | $981.70M 10-Q/A · filed 2009-08-17 | ||||||
| 2007-12-31 | $1.89B 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |